Epilepsy affects brain activities, leading to seizures and other serious health complications. The disease is often diagnosed in the young as well as the older population, making it difficult to monitor them regularly. As a result, healthcare companies invest heavily in developing neurostimulation devices to help with various symptoms of epilepsy. These devices can track seizures and protect against their serious side effects. In addition, they provide new options for treating drug-resistant epilepsy. With the expanding demand for seizure devices, the global epilepsy devices market is set to surge with a 7.83% CAGR between the assessment years 2022 and 2030.
According to the World Health Organization, over 5 million people worldwide are diagnosed with epilepsy yearly. In high-income countries, it is estimated that 49 out of 100,000 people are diagnosed with epilepsy. On the other hand, in low and middle-income countries, the number of people affected by epilepsy can be as high as 139 in every 100,000 due to the increased risk of endemics such as malaria or neurocysticercosis. Also, higher rates of road accidents, birth defects, variations in medical infrastructure, and the unavailability of preventive health programs and accessible care drive the numbers in these countries.
Trending Epilepsy Monitoring Devices
Advanced wearable seizure forecasting devices in the form of watches, bracelets, anti-suffocation pillows, smart stickers, etc., have a high demand for seizure monitoring as they offer complex functionalities, such as fall detection using accelerometers & gyroscopes, measuring blood oxygen with an echocardiogram (ECG), and temperature sensors for tracking ovulation cycles. Also, push for research and development to advance these technologies.
As these technologies become more refined, wearable neurostimulation devices will play a greater role in the healthcare process and boost their demand during the forecasted period. Monitoring devices can dramatically improve therapy assessment in treating patients and clinical trials. Furthermore, devices to detect physiological changes before a seizure and deliver therapies to prevent the seizure would be transformative, enabling new approaches to treating epilepsy.
Currently, smartwatches are the most popular and successful market sector of wearables. According to Scientific Reports, wearable wristband monitoring device data can indicate epileptic seizures before 30 minutes of their occurrence. The smartwatch space continues to innovate, making room for real-time or predictive responses. The skyrocketing success of these gadgets suggests more people are taking an interest in managing their health and well-being, monitoring activity levels and other health metrics. Some of the high-demand products include Apple Watch, mHealth application, etc.
Epilepsy bracelets are jewelry or cards that enable those in the wearer’s immediate vicinity to provide appropriate care during a seizure. These bracelets ease the identification of epileptic patients and treat them during an emergency. The information on these bracelets indicates emergency workers toward the patient’s medication list and health details to provide immediate medical assistance. According to American Medical ID (United States), an individual number and website are generally engraved for healthcare professionals to recognize. Custom engraving on these bracelets ensures medical ID accuracy, delivering precise and updated patient health information.
A common concern for epileptic individuals is suffocation from an airway blockage during a seizure while they are asleep. Suffocation-prevention pillows aid in lowering this danger. These pillows have an open cell structure and soft, porous foam that promotes ventilation. These pillows are advertised in the UK and internationally for use by persons with epilepsy and other diseases, although the Food and Drug Administration has not approved them. However, there is no proof that they even stop asphyxia from happening. Additional human experiments must be conducted to ascertain how these pillows lessen the danger of suffocation under more practical situations.
Intraoperative Neuromonitoring Devices
The easy availability of integrated communication systems and computer networks has enabled intraoperative neuromonitoring from a remote site, further increasing the potential application of the technique and helping further its popularity. Intraoperative neuromonitoring has also been utilized to significantly lower neurological damages caused during surgery and identify important neural structures in the operative field to minimize postoperative impairments.
In 2021, conventional devices, like EEG equipment, captured the majority of market shares under the product type segment. However, wearable devices are anticipated to be the fastest-growing by 2030. Healthcare industry giants like Medtronic PLC, Boston Scientific Corporation, Koninklijke Philips NV, etc., support research and encourage high-quality comparative efficacy trials and the lack of sufficient data to guide therapeutic practice in epilepsy. In addition to a focus on creating a more interconnected healthcare system for continuous monitoring, there has been an increase in the adoption of modern machine tech, like Machine Learning, Big Data, etc.
While several devices have been developed for epilepsy, only a handful have made it to clinical trials. As a result, there is a need for accurate and robust seizure prediction and detection devices. Compared to detecting electrographic events during a seizure, self-reporting often lacks quality since the seizure may affect consciousness.
Furthermore, utilizing powerful machine learning tools and Big Data for seizure prediction and detection paradigms also advances epilepsy monitoring technology, driving the global epilepsy devices market growth during the forecast period. Data assimilation, computational modeling, and analysis will enable real-time data classification, a mechanistic understanding of dynamical changes, and optimized epilepsy prevention and monitoring design.
What is the value of the global epilepsy devices market?
The global epilepsy devices market was valued at $611.26 million in 2021.
Which is the fastest-growing country in the global epilepsy devices market?
India is the fastest-growing country in the global epilepsy devices market.